Reuters logo
BRIEF-TiGenix granted orphan drug designation from FDA for CX601
October 23, 2017 / 5:12 AM / a month ago

BRIEF-TiGenix granted orphan drug designation from FDA for CX601

Oct 23 (Reuters) - TIGENIX NV:

* REG-TIGENIX GRANTED ORPHAN DRUG DESIGNATION FROM THE U.S. FDA FOR CX601 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below